Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma

American Journal of Dermatopathology

Volumn 27, Issue 2, 2005, Pages 96-101

  Grimes, Pearl E ^a,b,c   Yamada, Nanaka ^a,b,c   Bhawan, Jag ^d  

^a Vitiligo Pigmentation Inst S C   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD1A ANTIBODY; EOSIN; HEMATOXYLIN; MEL 5 ANTIBODY; MELANIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DENDRITE; DERMIS; ELECTRON MICROSCOPY; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LANGERHANS CELL; MALE; MELANOCYTE; MELANOSOME; MICROSCOPY; PRIORITY JOURNAL; PUNCH BIOPSY;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MELANINS; MELANOCYTES; MELANOSIS; MELANOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; SKIN;

EID: 16344370944     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000154419.18653.2e     Document Type: Article

References (24)

1. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453-1457.
2. Grimes PE. Disorders of hyperpigmentation. In: Sams WM, Lynch PJ, eds. Principles and Practice of Dermatology. 2nd ed. New York, New York: Churchill Livingstone; 1996:825-841.
3. Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40:455-458.
4. Gilchrest BA, Fitzpatrick TB, Anderson RR, et al. Localization of melasma pigmentation in the skin with Wood's lamp. Br J Dermatol. 1997;96:245-248.
5. Sanchez NP, Pathak MA, Fitzpatrick TB, et al. Melasma: A clinical, light microscopic, ultrastructural and immunofluorescence study. J Am Acad Dermatol. 1981;4:698-710.
6. Bhawan J. Mel-5: A novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffin-embedded sections. Melanoma Res. 1997;7:43-48.
7. Bhawan J, Gonzalez-Serva A, Nahal K. Effects of tretinoin on photodamaged skin. Arch Dermatol. 1991;127:666-672.
8. Blumberg RS, Gerdes D, Chott A, et al. Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev. 1995;147:5.
9. Pathak MA, Riley FC, Fitzpatrick TB. Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. J Invest Dermatol. 1962;39:435-443.
10. Fitzpatrick TB, Szabo G. The melanocyte: Cytology and cytochemistry. J Invest Dermatol. 1959;32:197-209.
11. Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228-237.
12. Gilchrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol. 1979;73:141-143.
13. Abdel-Malek Z, Swope V, Smalara D, et al. Analysis of UV induced melanogenesis and growth arrest of human melanocytes. Pigment Cell Res. 1994;7:326-332.
14. Barker D, Dixon K, Medrano EE, et al. Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B irradiation. Cancer Res. 1995;55:4041-4046.
15. Luger TA, Schwartz T. Evidence for an epidermal cytokine network. J Invest Dermatol. 1990;95:1005-1045.
16. Schauer E, Trautinger F, Kock A, et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest. 1994;93:2258-2262.
17. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as new melanogen: Coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol. 1995;105:32-37.
18. Smit N, LePoole I, Vanden Winjngaard R, et al. Expression of different immunological markers by culotured human melanocytes. Arch Dermatol Res. 1993;285:356-365.
19. Im S, Kim J, On WY, et al. Increased expression of alpha-melanocyte- stimulating hormone in the lesional skin of melasma. Br J Dermatol. 2002;146:165-167.
20. Nordlund JJ, Abdel-Malek ZA for Proceedings of the XIII International Pigment Cell Society. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. In: Bagnara J, ed. Advances in Pigment Cell Research. New York, New York: Alan R Less; 1998:219-236.
21. 2μ in human skin following ultraviolet B irradiation. Br J Clin Pharmacol. 1980;10:453-457.
22. Tomita Y, Iwamoto M, Masuda T, et al. Stimulating effect of prostaglandin E2 on the configuration of normal human melanocytes. J Invest Dermatol. 1987;89:229-301.
23. 3, μ melanocyte stimulating hormone and Beta-estradiol. J Invest Dermatol. 1988;91:593-598.
24. Jee SH, Lee SY, Chiu HC, et al. Effects of estrogen and estrogen receptors in normal human melanocytes. Biochem Biophys Res Commun. 1994;199:1407-1412.